Speedy FDA Drug Reviews On The Horizon

Law360, New York (April 3, 2012, 12:46 PM EDT) -- Congress is taking steps to ensure that drugs and biological products reach the market sooner. Provisions included in the draft U.S. Food and Drug Administration (FDA) user-fee legislation unveiled by the U.S. House Energy and Commerce Committee in early March 2012 would expand drug developers' access to the FDA's "accelerated approval" program.

These provisions had originally been introduced in the Faster Access to Specialized Treatments Act, HR 4132, co-sponsored by Reps. Cliff Stearns, R-Fla., and Edolphus Towns, D-N.Y. The inclusion of these provisions in the user-fee...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.